Welcome to GENESIS Hangzhou!

page_banner

news

The SARS-CoV-2 Rapid Antigen Test is a reliable, rapid chromatopgraphic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2 present in the human nasopharynx. This test is an aid in detecting antigen from the SARS-CoV-2 virus in individuals suspected of COVID-19.
 
In France market for use by health professionals – distribution only when local regulation permits. Genesis KaiBiLi COVID-19 antigen test already get the permits in France.
m1
Novel Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (nasal swab) is an in vitro diagnostic test for the qualitative detection Nucleoprotein of Coronavirus Disease 2019 in human nasal swab, using the rapid immunochromatographic method as an aid in the diagnosis of SARS-Cov-2 infections. The identification is based on the monoclonal antibodies specific for the novel coronavirus antigen. It will provide information for clinical doctors to prescribe correct medications.
Our Antigen Rapid test devices are in vitro immunological tests. The purpose of the tests are to detect directly and qualitatively SARS-CoV-2 antigen from samples of nasopharyngeal secretions.
 


Post time: Aug-09-2021